Loading…
Loading…
EQUITY / NASDAQ · XNCM
Sanara MedTech Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗34.85 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 34.85 USD · Volume 341,857
64 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Revenue | 28,136,757 USD | 25,804,252 USD | +9.04% |
| Operating profit | 1,780,377 USD | 2,487,309 USD | -28.42% |
| Net income | -452,864 USD | -2,014,362 USD | — |
| Cash and cash equivalents | 15,421,170 USD | — | — |
| Total liabilities | 61,211,927 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 15,421,170 USD | — | — | 16,578,857 USD | 16,578,857 USD | 14,939,646 USD | — | — |
| Gross profitIncome statement | 26,155,410 USD | 52,030,355 USD | — | — | 95,597,013 USD | 24,459,605 USD | 69,925,704 USD | 23,866,970 USD |
| Net incomeIncome statement | -452,864 USD | 6,093 USD | 458,603 USD | — | -37,562,606 USD | -30,411,153 USD | -35,952,692 USD | -2,014,362 USD |
| Operating profitIncome statement | 1,780,377 USD | 4,426,958 USD | — | — | 7,304,538 USD | 2,941,240 USD | 6,254,079 USD | 2,487,309 USD |
| RevenueIncome statement | 28,136,757 USD | 55,935,291 USD | — | — | 103,117,982 USD | 26,333,819 USD | 75,572,167 USD | 25,804,252 USD |
| Total assetsBalance sheet | 69,146,387 USD | — | — | 72,944,071 USD | 72,944,071 USD | 71,088,648 USD | — | — |
| Total equityBalance sheet | 7,943,480 USD | — | 7,019,495 USD | 5,938,442 USD | 5,938,442 USD | 6,148,956 USD | — | 35,391,946 USD |
| Total liabilitiesBalance sheet | 61,211,927 USD | — | — | 67,014,295 USD | 67,014,295 USD | 64,948,114 USD | — | — |
| Capital expendituresCash flow statement | — | 49,052 USD | — | — | 4,625,650 USD | — | 4,543,491 USD | — |
| Financing cash flowCash flow statement | — | -681,700 USD | — | — | 8,887,823 USD | — | 8,748,396 USD | — |
| Investing cash flowCash flow statement | — | -49,052 USD | — | — | -14,973,890 USD | — | -12,528,613 USD | — |
| Operating cash flowCash flow statement | — | -426,935 USD | — | — | 6,786,629 USD | — | 2,841,568 USD | — |
| Report source | Open report ↗ Published: 08/11/2026 | Open report ↗ Published: 08/11/2026 | Open report ↗ Published: 08/11/2026 | Open report ↗ Published: 08/11/2026 | Open report ↗ Published: 03/24/2026 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 08/11/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.